Literature DB >> 3943702

Obstructive cholangitis secondary to mucus secreted by a solitary papillary bile duct tumor.

P Styne, G H Warren, D A Kumpe, C Halgrimson, F Kern.   

Abstract

A middle-aged woman had repeated episodes of common bile duct obstruction and cholangitis caused by profuse secretion of mucus by a solitary papillary tumor in the left hepatic duct. This complication usually occurs only with papillomatosis. The tumor initially appeared to be benign but subsequently was proven to be an invasive adenocarcinoma. Although the tumor recurred after surgical resection, her course remained uneventful without spread of the neoplasm for 3 yr.

Entities:  

Mesh:

Year:  1986        PMID: 3943702     DOI: 10.1016/0016-5085(86)91133-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

1.  Clinical studies of mucin-producing cholangiocellular carcinoma: a study of 22 histopathology-proven cases.

Authors:  M F Chen; Y Y Jan; T C Chen
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

2.  Rare event of biliary papillomatosis arising in a choledochal cyst.

Authors:  Kumar Nishant; Varun Kumar Singh; Barun Kumar Sharma
Journal:  BMJ Case Rep       Date:  2014-07-02

3.  Carcinoma in situ arising in a tubulovillous adenoma of the distal common bile duct: a case report.

Authors:  Bum-Soo Kim; Sun-Hyung Joo; Kwang-Ro Joo
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

4.  Adenomas involving the extrahepatic biliary tree are rare but have an aggressive clinical course.

Authors:  Kah Poh Loh; Deborah Nautsch; James Mueller; David Desilets; Vaibhav Mehendiratta
Journal:  Endosc Int Open       Date:  2015-11-27

5.  Mucin-hypersecreting bile duct neoplasm characterized by clinicopathological resemblance to intraductal papillary mucinous neoplasm (IPMN) of the pancreas.

Authors:  Yo-Ichi Yamashita; Kengo Fukuzawa; Akinobu Taketomi; Shinichi Aishima; Tomoharu Yoshizumi; Hideaki Uchiyama; Eiji Tsujita; Norifumi Harimoto; Noboru Harada; Kenzo Wakasugi; Yoshihiko Maehara
Journal:  World J Surg Oncol       Date:  2007-08-28       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.